Literature DB >> 8523578

A herpesvirus saimiri membrane protein required for interleukin-2 independence forms a stable complex with p56lck.

T Lund1, M M Medveczky, P J Neame, P G Medveczky.   

Abstract

ORF-2, a 32-kDa viral protein expressed by herpesvirus saimiri-transformed lymphocytes, is essential for transformation and is expressed on the plasma membrane of transformed cells. The current work now shows that most (approximately 80%) of ORF-2 resides in the cytoplasm, while only a small portion protrudes from the cell surface. Expressed as a glutathione S-transferase fusion protein, ORF-2 was found to interact with a 56-kDa cellular protein in untransformed, herpesvirus saimiri-transformed, and Jurkat lymphocytes. Microsequencing proved that this protein is the lymphocyte-specific tyrosine protein kinase p56lck. Two regions of ORF-2 were found to be required for p56lck interaction. Current evidence suggests that the interaction of ORF-2 with p56lck plays a key role in the specific transformation of T lymphocytes to an interleukin-2-independent phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523578      PMCID: PMC189852     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  Internal protein sequence analysis: enzymatic digestion for less than 10 micrograms of protein bound to polyvinylidene difluoride or nitrocellulose membranes.

Authors:  J Fernandez; M DeMott; D Atherton; S M Mische
Journal:  Anal Biochem       Date:  1992-03       Impact factor: 3.365

4.  T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck.

Authors:  I D Horak; R E Gress; P J Lucas; E M Horak; T A Waldmann; J B Bolen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.

Authors:  M Hatakeyama; T Kono; N Kobayashi; A Kawahara; S D Levin; R M Perlmutter; T Taniguchi
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

6.  Association of p60fyn with middle tumor antigen in murine polyomavirus-transformed rat cells.

Authors:  I D Horak; T Kawakami; F Gregory; K C Robbins; J B Bolen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  The divergence between two oncogenic Herpesvirus saimiri strains in a genomic region related to the transforming phenotype.

Authors:  B Biesinger; J J Trimble; R C Desrosiers; B Fleckenstein
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

8.  Thymic tumorigenesis induced by overexpression of p56lck.

Authors:  K M Abraham; S D Levin; J D Marth; K A Forbush; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes.

Authors:  R K Cheung; H M Dosch
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

10.  Stable growth transformation of human T lymphocytes by herpesvirus saimiri.

Authors:  B Biesinger; I Müller-Fleckenstein; B Simmer; G Lang; S Wittmann; E Platzer; R C Desrosiers; B Fleckenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more
  16 in total

Review 1.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

2.  Functional characterization and conformational analysis of the Herpesvirus saimiri Tip-C484 protein.

Authors:  Jennifer L Mitchell; Ronald P Trible; Lori A Emert-Sedlak; David D Weis; Edwina C Lerner; Jeremy J Applen; Bartholomew M Sefton; Thomas E Smithgall; John R Engen
Journal:  J Mol Biol       Date:  2006-12-16       Impact factor: 5.469

3.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Primary structure of the Herpesvirus ateles genome.

Authors:  J C Albrecht
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri.

Authors:  K T Hall; M S Giles; D J Goodwin; M A Calderwood; I M Carr; A J Stevenson; A F Markham; A Whitehouse
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells.

Authors:  A Knappe; C Hiller; M Thurau; S Wittmann; H Hofmann; B Fleckenstein; H Fickenscher
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Herpesvirus ateles gene product Tio interacts with nonreceptor protein tyrosine kinases.

Authors:  J C Albrecht; U Friedrich; C Kardinal; J Koehn; B Fleckenstein; S M Feller; B Biesinger
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck activity in T cells.

Authors:  T Lund; M M Medveczky; P G Medveczky
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

10.  The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells.

Authors:  T C Lund; P C Prator; M M Medveczky; P G Medveczky
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.